Home Cart 0 Sign in  

[ CAS No. 1343476-44-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1343476-44-7
Chemical Structure| 1343476-44-7
Structure of 1343476-44-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1343476-44-7 ]

Related Doc. of [ 1343476-44-7 ]

Alternatived Products of [ 1343476-44-7 ]

Product Details of [ 1343476-44-7 ]

CAS No. :1343476-44-7 MDL No. :MFCD32641649
Formula : C15H23N3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :NNWYWNRCBPYLML-GWCFXTLKSA-N
M.W : 293.36 Pubchem ID :68223172
Synonyms :

Calculated chemistry of [ 1343476-44-7 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.47
Num. rotatable bonds : 8
Num. H-bond acceptors : 4.0
Num. H-bond donors : 4.0
Molar Refractivity : 81.43
TPSA : 104.45 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.79 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.2
Log Po/w (XLOGP3) : 0.42
Log Po/w (WLOGP) : 0.26
Log Po/w (MLOGP) : 0.46
Log Po/w (SILICOS-IT) : 1.01
Consensus Log Po/w : 0.87

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.61
Solubility : 7.25 mg/ml ; 0.0247 mol/l
Class : Very soluble
Log S (Ali) : -2.18
Solubility : 1.94 mg/ml ; 0.0066 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.17
Solubility : 0.199 mg/ml ; 0.000678 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.71

Safety of [ 1343476-44-7 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1343476-44-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1343476-44-7 ]

[ 1343476-44-7 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 55750-53-3 ]
  • [ 1343476-44-7 ]
  • [ 1870916-87-2 ]
YieldReaction ConditionsOperation in experiment
52% With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 2h;
With 4-methyl-morpholine; N-[(1H-1,2,3-benzotriazol-1-yloxy)(dimethylamino)methylene]-N-methylmethanaminium tetrafluoroborate In N,N-dimethyl-formamide
  • 2
  • [ 1343476-44-7 ]
  • [ 1639939-40-4 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 4-methyl-morpholine; N-[(1H-1,2,3-benzotriazol-1-yloxy)(dimethylamino)methylene]-N-methylmethanaminium tetrafluoroborate / N,N-dimethyl-formamide 2: N,N-dimethyl-formamide
Multi-step reaction with 2 steps 1: N,N-dimethyl-formamide / 6 h / 20 °C 2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 5 h / 20 °C
Multi-step reaction with 2 steps 1: N,N-dimethyl-formamide / 20 °C 2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 5 h / 20 °C
Multi-step reaction with 2 steps 1: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 2 h / 20 °C 2: N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 16 h / 20 °C

  • 3
  • [ CAS Unavailable ]
  • [ 1343476-44-7 ]
  • [ 1870916-87-2 ]
YieldReaction ConditionsOperation in experiment
87% In N,N-dimethyl-formamide at 20℃; for 6h;
86% In N,N-dimethyl-formamide at 20℃; 3.2.9 Synthesis of 6-(2,5-dioxo-2,5-dihydro-1h-pyrrole-1-yl)-N-[(s)-1-[(s)-1-[4-(hydroxymethyl) phenyl] amino}-1-oxopropan-2-yl] amino}-3-methyl-1-oxobutan-2-yl] hexanamide (12) Compound 10 (1.5g, 5.1mmol) was completely dissolved in 50mL of N,N-dimethylformamide. Compound 4 (1.89g, 6.1mmol) was added to the mixture and reacted overnight at room temperature. After the reaction, the mixture was concentrated under a reduced pressure and purified via column chromatography (dichloromethane:methanol=50:1 to 10:1 gradient elution). 2.13g of solid compound 12 were obtained at an 86% yield. 1H NMR (400MHz, DMSO-d6): δ 9.86 (s, 1H), 8.15 (d, J=7.0Hz, 1H), 7.82 (d, J=8.7Hz, 1H), 7.52 (d, J=8.5Hz, 2H), 7.21 (d, J=8.5Hz, 2H), 7.00 (s, 2H), 5.10 (t, J=5.7Hz, 1H), 4.41 (d, J=5.6Hz, 2H), 4.38 - 4.33 (m, 1H), 4.15 (dd, J=8.7, 6.9Hz, 1H), 3.37 (s, 2H), 2.20 - 2.09 (m, 2H), 1.98 - 1.90 (m, 1H), 1.55 - 1.39 (m, 4H), 1.28 (d, J=7.1Hz, 3H), 1.20 - 1.12 (m, 2H), 0.83 (dd, J=16.6, 6.8Hz, 6H). ESI m/z: calculated for C25H34N4O6 486.3, found 487.5 [M+H]+.
Same Skeleton Products
Historical Records